The text from her son Randy that Heather Bacchus received at at 1:26 AM on July 17, 2021, seemed like good news. “I’m quitting weed for good and want to surround myself with healthy and happy people,” he wrote. “This has been too much for me and for you guys.” Less than an hour later,
Published online by Cambridge University Press: 04 May 2023 Carsten Hjorthøj[, Wilson Compton, Marie Starzer, Dorte Nordholm ,Emily Einstein, Annette Erlangsen, Merete Nordentoft ,Nora D. Volkow and Beth Han Abstract Background Previous research suggests an increase in schizophrenia population attributable risk fraction (PARF) for cannabis use disorder (CUD). However, sex and age variations in CUD and schizophrenia
Long ago, the THC content of weed was less than 1.5%. Today some marijuana products have more than 90%. It’s making people sick, and regulators have failed to keep up. Marijuana and other products containing THC, the plant’s main psychoactive ingredient, have grown more potent and more dangerous as legalization has made them more widely available.
Edoardo Spinazzola1,* , Diego Quattrone2,3,4,* , Victoria Rodriguez1, Giulia Trotta2 , Luis Alameda1,5,6 , Giada Tripoli1,7 ,Charlotte Gayer-Anderson8 , Tom P Freeman9,10, Emma C Johnson11, Hannah E Jongsma12, Simona Stilo1,13, Caterina La Cascia7, Laura Ferraro7, Daniele La Barbera7, Antonio Lasalvia14, Sarah Tosato14, Ilaria Tarricone15, Giuseppe D’Andrea15, Michela Galatolo15, Andrea Tortelli16,17,Ilaria Tagliabue18,19, Marco Turco18, Maurizio Pompili20,
NIH study highlights the need to proactively screen for, prevent, and treat cannabis use disorder, especially among young people May 4, 2023 ©Getty Images/Nikola Stojadinovic Young men with cannabis (marijuana) use disorder have an increased risk of developing schizophrenia, according to a study led by researchers at the Mental Health Services in the Capital Region of
The IASIC board of directors would like to thank our Expert Physician Council, Expert Affiliate Council and Donors for your support in creating IASIC and contributing to a successful first year. We could not have achieved what we did without you. A heartful thank you to all of you as we reflect on 2022 and share
Background The hypothesis that marijuana availability reduces opioid mortality merits more complete testing, especially in a country with the world’s highest opioid death rate and 2nd highest cannabis-use-disorder prevalence. Methods The United States opioid mortality rate was compared in states and District of Columbia that had implemented marijuana legalization with states that had not, by
The International Academy on the Science and Impact of Cannabis (IASIC) is a group led by doctors educating on marijuana. We counter the pervasive misconception of the safety of marijuana with international experts who provide science, data, and clinical expertise. This non-partisan and non-political group is developed, organized, and guided by doctors. We hope science
IASIC, the International Academy on the Science and Impact of Cannabis, is a medical organization of doctors who educate on marijuana based on the scientific and medical literature. IASIC is a non-partisan and non-political group created to facilitate informed decisions when considering cannabis policy and law. If you saw the recent ad in the November 6/7, 2021
Hear a discussion with Dr. Bertha Madras on High Truths on Drugs and Addiction, Episode #12. Dr. Madras is an IASIC scientific advisor, Harvard Professor and former White House Office of National Drug Control Policy Deputy Director of Demand Reduction. In episode #12, Dr. Madras explains the importance and possible prevention of drug use. The
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
